Крысанов Иван Сергеевич
175 works · 116 citations · h-index 4
Top works
- Evaluation of orphan diseases global burden
- Analysis of Russian pharmaceutical specialists labor market for 2019–2022
- Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
- Mosunetuzumab budget impact analysis in patients with recurrent or refractory follicular lymphoma
- Modelling the economic effects of HPV-vaccination for adolescents of both sexes
- Dynamics of turnover of sugar-lowering drugs in the retail segment of the pharmaceutical market from 2020 to 2024
- Analysis of drug therapy for patients with metastatic melanoma of the skin using the example of the Moscow region
- Characteristics of purchases of hypoglycemic agents in pharmacy retail sector in 2016–2020 years dynamics
- Фармакоэкономика сахарного диабета
- Comparative pharmacoeconomic analysis of the use of Bonviva® (ibandronat) to prevent fractures in postmenopausal osteoporosis
- RATIONAL SUPPORTIVE THERAPY FOR CHEMOTHERAPY INDUCED ANEMIA: A PHARMACO-ECONOMIC ANALYSIS OF ERYTHROPOIETIN THERAPY IN CANCER PATIENTS IN RUSSIAN FEDERATION
- A social-economic burden of rhinosinusitis with nasal polyps with comorbid asthma and influence of dupilumab
- Using of Monofocal Intraocular Lenses Different Types for Cataract Surgery in Adult Patients: Systematic Review
- PHM9 COST OF ILLNESS OF DIFFUSE LARGE B-CELL LYMPHOMA IN RUSSIA
- COST-MINIMIZATION ANALYSIS OF USING SHORT AND LONG-ACTING ERYTHROPOESIS-STIMULATING AGENTS FOR CORRECTION OF NEPHROGENIC ANEMIA AGAINST THE BACKGROUND OF SUBSTITUTION THERAPY
- Clinical and economic justification of screening for mucopolysaccharidosis type I in children at groups of risks
- Comparative clinical and economic analysis of pozaconazol (Noxafil) for invasive mycoses (IM) prevention in patients with severe neutropenia during treatment of acute myeloid leukemia or myelodysplastic syndrome
- THE ECONOMIC COSTS OF CORRECTION OF ADVERSE DRUG REACTIONS IN THERAPEUTIC PATIENTS
- [Methodology of new pharmacoeconomic method "impact on hospital budget" by the example of local hemostatic agents in abdominal surgery].
- Th e clinical-economic analysis of Dupilumab in severe asthma